Featured Products

Upcoming Conventions & Events

  • Octreoscan Voluntary Recall

    Click here for 1/7/10 Octreoscan DHCP Letter

    Please note important safety updates for Optimark™ (gadoversetamide injection), effective November 6, 2009.

    Click here for 11/6/09 updated boxed warning and important safety information

    Click here for 11/6/09 Optimark DHCP letter

    All barium products and accessories will be discontinued effective January 15, 2010. Please see the attached customer letter for details regarding the discontinuation of these products.

    Customer Letter

    Covidien Responds to Molybdenum 99 Supply Shortage

    Click here for current information www.covidien.com/Mo99supply

  • 12/17/2009 8:03:00 AM

    Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies

    DUBLIN, Dec 17, 2009 (BUSINESS WIRE) -- Covidien (NYSE: COV), a leading global provider of healthcare products, today announced a definitive agreement to sell its radiopharmacies in the United States to Triad Isotopes, Inc. of Orlando, Florida. Triad operates a network of 26 nuclear radiopharmacies and six cyclotron facilities in the southeast United States. Financial terms of the transaction were not disclosed. …

  • 1/21/2010 4:02:00 PM

    Covidien Declares Quarterly Cash Dividend

    DUBLIN, Jan 21, 2010 (BUSINESS WIRE) -- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.18 per ordinary share. The dividend is payable on February 23, 2010, to shareholders of record on February 1, 2010. ABOUT COVIDIEN …

  • 1/20/2010 6:03:00 AM

    Covidien Reports First-Quarter 2010 Results

    Net sales up 7%, led by an 18% increase for Medical DevicesDiluted GAAP earnings per share from continuing operations were $0.82; excluding specified items, adjusted diluted earnings per share from continuing operations were $0.86Fiscal 2010 operating margin guidance raised …